Abu Dhabi, UAE: The Department of Health - Abu Dhabi has approved the use of EDE scanners to detect Covid-19 infections, after studying the results of the pilot trial conducted at various locations in the emirate, including the Ghantout entry point, select public locations on Yas Island, and entry/exit points in the Musaffah area. 

With more than 20,000 people tested, the results showed a high degree of effectiveness in using EDE scanners to detect a positive Covid-19 infection. The results showed 93.5 per cent sensitivity, reflecting the accuracy of identifying infected individuals, and 83 per cent accuracy in the specificity of the test, reflecting the accuracy of identifying non-infected individuals.

His Excellency Dr Jamal Mohammed Al Kaabi, Undersecretary at Department of Health - Abu Dhabi, said: “Abu Dhabi has adopted an integrated strategy to combat the Covid-19 pandemic, based on increased testing to ensure safe entry into the emirate, vaccination and the continued implementation of precautionary measures.

“The use of the EDE scanning system is part of this strategy and reflects the leadership’s vision in harnessing modern technology to create solutions that turn challenges into opportunities. We are pleased to add EDE scanning technology made in Abu Dhabi to the precautionary measures, helping to create safer areas and maintain public health. The EDE scanners will be used alongside other approved testing methods, such as PCR and DPI.”

The scanning system was developed by EDE Research Institute Abu Dhabi under the International Holding Company (IHC). The technology can detect a possible Covid-19 infection by measuring electromagnetic waves, which change when the RNA particles of the virus are present in the person’s body, therefore providing an immediate result.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.